期刊文献+

溶血卵磷脂对人视网膜内皮细胞表达糖基化终产物受体的影响

Effect of LPC Increases Advanced Glycation End Products Receptor Expression in Human Retinal Endothelial Cells
下载PDF
导出
摘要 目的:探讨不同浓度的溶血卵磷脂(LPC)对人视网膜微血管内皮细胞表达糖基化终产物受体的影响。方法:人视网膜内皮细胞加入不同浓度的LPC:(20μmol/L,40μmol/L,60μmol/L)和糖基化终产物,培养24 h,Real-time(RT)-PCR检测糖基化终末产物受体(RAGE)m RNA表达水平,Western blot检测RAGE蛋白表达水平。结果:Realtime(RT)-PCR及Western blot结果表明,LPC的溶度为60 umol/L作用24 h后,RAGE的m RNA及蛋白表达水平明显高于溶度为20μmol/L、40μmol/L。结论:LPC能促进人视网膜内皮细胞RAGE的表达,并且呈剂量依赖性。 Objective The aim of the present study was to investigate the effect of LPC on expression of glycation end products receptor(RAGE) in human retinal endothial cells. Methods HRECs were treated or not treated with AGEs in the presence or absence of LPC, The expression of RAGE were assessed by Western blot analysis using specific antibodies and Real Time-PCR. Results Real-time-PCR and western blot results showed that RAGE expression levels were significantly higher with treatment of LPC 60 umol/L for 24 hours than LPC 20 umol/L, 40 umol/L. Conclusion These results demonstrate that treatment of HRECs with LPC caused dose- dependent increases in RAGE expression.
机构地区 贵州省人民医院
出处 《深圳中西医结合杂志》 2015年第12期1-3,F0003,共4页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
基金 贵州省科学技术基金资助项目(黔科合J字[2009]2)
关键词 溶血卵磷脂 糖基化终产物受体 糖尿病视网膜病变 Lysophosphatidylcholine Advanced glycation end products receptor Diabetic rerinopathy
  • 相关文献

参考文献11

  • 1Nowotny K,Jung T, H6hn A,et al.Advanced glycation end products and oxidative stress in type 2 diabetes mellitus [J] . Biomolecules,2015, 5(1):194-222.
  • 2Matsumoto T, Kobayashi T, Kamata K. Role of lysophospha tidylcholine(LPC) in athero-sclerosis [J] .Curr Med Chem,2007,14(30): 3209-3220.
  • 3Nosadini R,Tonolo G.Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes ( J ) . Nutr Metab Cardiovasc Dis ,201 l, 21 (2): 79-85.
  • 4Abdolahi A, Georas SN, Brenna JT, et al.The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus [J] .Prostaglandins Leukot Essent Fatty Acids. 2014,90(2-3):61-68.
  • 5Iwase M,Sonoki K,Sasaki N,et al.Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment [J] . Atherosclerosis ,2008,196(2): 931-936.
  • 6Noori N, Tabibi H, Hosseinpanah F,et al.Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabeticnephropathy [J] .Int J Vitam Nutr Res. 2013,83(2):77-85.
  • 7Gholamin S, Razavi SM, Taghavi SM,et al.Lovastatin forreduction of leptin in nondialysis patients with type 2 diabetic nephropathy [J] .Iran J Kidney Dis. 2014,8(3):201- 206.
  • 8Tolonen N, Hietala K, Forsblom C,et al.Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study [J] . Intern Med, 2013,274(5):469-479.
  • 9Aldebasi YH, Mohieldein AH, Almansour YS,et al. Dyslipidemia and lipid peroxidation of Saudi type 2 diabetics with proliferative retinopathy [J] .Saudi Med,2013,34(6):616-622.
  • 10Tryggestad JB, Willi SM.Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial [J] .Diabetes Complications, 2015,29(2):307-312.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部